Adam Osinski

541 total citations
10 papers, 347 citations indexed

About

Adam Osinski is a scholar working on Endocrinology, Molecular Biology and Epidemiology. According to data from OpenAlex, Adam Osinski has authored 10 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Endocrinology, 3 papers in Molecular Biology and 3 papers in Epidemiology. Recurrent topics in Adam Osinski's work include Legionella and Acanthamoeba research (3 papers), Autophagy in Disease and Therapy (3 papers) and Enzyme Structure and Function (3 papers). Adam Osinski is often cited by papers focused on Legionella and Acanthamoeba research (3 papers), Autophagy in Disease and Therapy (3 papers) and Enzyme Structure and Function (3 papers). Adam Osinski collaborates with scholars based in United States, Poland and Sweden. Adam Osinski's co-authors include Diana R. Tomchick, Krzysztof Pawłowski, Vincent S. Tagliabracci, Sung Jun Bae, Lisheng Ni, Chad A. Brautigam, Xuelian Luo, Kelly A. Servage, Zhe Chen and John W. Schoggins and has published in prestigious journals such as Nature, Science and Journal of Biological Chemistry.

In The Last Decade

Adam Osinski

9 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adam Osinski United States 6 190 119 88 62 46 10 347
Andrey S. Selyunin United States 8 186 1.0× 68 0.6× 104 1.2× 47 0.8× 49 1.1× 9 330
Bethany A. Weigele United States 5 162 0.9× 60 0.5× 93 1.1× 45 0.7× 59 1.3× 5 311
Simon R. Bushell United Kingdom 8 163 0.9× 33 0.3× 42 0.5× 95 1.5× 35 0.8× 10 381
Julia Blümer Germany 8 377 2.0× 220 1.8× 193 2.2× 93 1.5× 9 0.2× 10 587
R. Scott Houliston Canada 14 350 1.8× 32 0.3× 32 0.4× 61 1.0× 41 0.9× 19 500
Akihiko Koizumi Japan 13 277 1.5× 61 0.5× 19 0.2× 51 0.8× 26 0.6× 22 416
Kyoung Hoon Kim South Korea 10 282 1.5× 39 0.3× 16 0.2× 51 0.8× 108 2.3× 15 431
Gabriella Siszler Germany 7 283 1.5× 17 0.1× 81 0.9× 43 0.7× 50 1.1× 8 429
Mathieu S. Chevalier United States 8 171 0.9× 121 1.0× 12 0.1× 67 1.1× 23 0.5× 10 338
Louis D. Heerze Canada 8 341 1.8× 27 0.2× 46 0.5× 82 1.3× 35 0.8× 10 478

Countries citing papers authored by Adam Osinski

Since Specialization
Citations

This map shows the geographic impact of Adam Osinski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Osinski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Osinski more than expected).

Fields of papers citing papers by Adam Osinski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Osinski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Osinski. The network helps show where Adam Osinski may publish in the future.

Co-authorship network of co-authors of Adam Osinski

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Osinski. A scholar is included among the top collaborators of Adam Osinski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Osinski. Adam Osinski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Hernandez, Genaro, Adam Osinski, Jennifer L. Eitson, et al.. (2025). Covalent inhibition of the SARS-CoV-2 NiRAN domain via an active-site cysteine. Journal of Biological Chemistry. 301(4). 108378–108378.
2.
Osinski, Adam & Vincent S. Tagliabracci. (2023). A domain of all trades: The enzymatic versatility of the NiRAN domain. Molecular Cell. 83(21). 3758–3760. 1 indexed citations
3.
Pon, Alex, Adam Osinski, & Anju Sreelatha. (2023). Redefining pseudokinases: A look at the untapped enzymatic potential of pseudokinases. IUBMB Life. 75(4). 370–376. 5 indexed citations
4.
Osinski, Adam, Genaro Hernandez, Jennifer L. Eitson, et al.. (2022). The mechanism of RNA capping by SARS-CoV-2. Nature. 609(7928). 793–800. 76 indexed citations
5.
Tagliabracci, Vincent S., et al.. (2022). Structural and mechanistic basis for protein glutamylation by the kinase fold. The FASEB Journal. 36(S1). 1 indexed citations
6.
Hsieh, Ting‐Sung, Víctor López, Adam Osinski, et al.. (2021). Dynamic remodeling of host membranes by self-organizing bacterial effectors. Science. 372(6545). 935–941. 22 indexed citations
7.
Osinski, Adam, et al.. (2021). Structural and mechanistic basis for protein glutamylation by the kinase fold. Molecular Cell. 81(21). 4527–4539.e8. 20 indexed citations
8.
Osinski, Adam, et al.. (2021). A Legionella effector ADP-ribosyltransferase inactivates glutamate dehydrogenase. Journal of Biological Chemistry. 296. 100301–100301. 12 indexed citations
9.
Osinski, Adam, et al.. (2019). Bacterial pseudokinase catalyzes protein polyglutamylation to inhibit the SidE-family ubiquitin ligases. Science. 364(6442). 787–792. 100 indexed citations
10.
Bae, Sung Jun, Lisheng Ni, Adam Osinski, et al.. (2017). SAV1 promotes Hippo kinase activation through antagonizing the PP2A phosphatase STRIPAK. eLife. 6. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026